【  Drug Name 】: Chlorquinaldol-Promestriene Vaginal Tablets 
[English Name]:  Chlorquinaldol Promestriene Vaginal Tablets
Approval number:
National Pharmaceutical Approval Letter H20065500
【 Prescription Type 】: Prescription drug Rx
[Medical Insurance Type]: Non medical insurance
[Drug Type]: Chemicals
[Production Enterprise]:Beijing Silian Pharmaceutical Co., Ltd
[Indications]: This product is suitable for any cause of increased vaginal discharge, except for gonococcal infections.
[Usage and Dosage]:
1. Take one tablet daily for 18 consecutive days. The medication method can also be adjusted according to medical advice.
2. Administration route: Vaginal administration. Put the already moistened tablet into the deep part of the vagina, and it is recommended to use this medicine in the evening.
[Side effects]:
Like all medications, this product can cause discomfort in some patients, with occasional irritation, itching, allergic reactions, etc.
Taboos:
Although no systemic reactions were observed after the use of this medication, as a preventive measure against the use of any estrogen, it is recommended that patients with a history of estrogen dependent cancer do not use this medication.
Ingredients:
This product is a compound preparation, consisting of chloroquinaldol and proestrene.
[Character]:
This product is a light yellow to slightly mottled vaginal tablet (if there are trace flocculent substances on the surface of the tablet, it is a normal phenomenon).
【 Precautions 】:
1. Keep out of reach of children.
2. Pregnant and lactating women should not use this medication during pregnancy, and it is not recommended to use this medication during lactation.
3. Children's medication: There is no relevant data on children's medication yet.
4. Elderly medication: There is currently no relevant data on elderly medication.
5. Overdose: The administration route and absorption process of this drug require that it should not be overused.
Pharmacological effects:
1. Prolestrone acts on the mucosa of the lower reproductive tract, exerting a local estrogenic effect, thus restoring the nourishing properties of the lower reproductive tract.
2. After vaginal administration, no systemic effects of estrogen were observed, especially in estrogen sensitive organs far from the vagina.
3. Chloroquinaldol is a broad-spectrum antibacterial agent.